ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,080.96
0.90%
Dow Jones
38,282.45
1.23%
US Dollar vs MXN
17.007
-0.85%
Brent Oil
83.525
-2.76%
Bitcoin
59,248.05
-2.23%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. X4 Pharmaceuticals Inc (XFOR)

  7. X4 Pharmaceuticals Inc (XFOR) Noticias

XFOR

X4 Pharmaceuticals (XFOR)

X4 Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XFOR
FechaHoraFuenteTítuloSímboloCompañía
11/03/202416:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XFORX4 Pharmaceuticals Inc
11/03/202415:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XFORX4 Pharmaceuticals Inc
28/02/202416:52Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:XFORX4 Pharmaceuticals Inc
14/02/202415:44Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:XFORX4 Pharmaceuticals Inc
14/02/202415:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XFORX4 Pharmaceuticals Inc
25/01/202415:23Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XFORX4 Pharmaceuticals Inc
08/01/202415:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XFORX4 Pharmaceuticals Inc
09/11/202316:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XFORX4 Pharmaceuticals Inc
18/10/202315:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XFORX4 Pharmaceuticals Inc
24/08/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XFORX4 Pharmaceuticals Inc
26/06/202315:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XFORX4 Pharmaceuticals Inc
23/06/202314:27Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:XFORX4 Pharmaceuticals Inc
21/06/202305:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XFORX4 Pharmaceuticals Inc
21/06/202305:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:XFORX4 Pharmaceuticals Inc
16/06/202315:05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XFORX4 Pharmaceuticals Inc
09/06/202315:13Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:XFORX4 Pharmaceuticals Inc
01/06/202315:40Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:XFORX4 Pharmaceuticals Inc
01/06/202315:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XFORX4 Pharmaceuticals Inc
26/05/202314:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XFORX4 Pharmaceuticals Inc
04/05/202315:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XFORX4 Pharmaceuticals Inc
27/04/202315:27Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XFORX4 Pharmaceuticals Inc
25/04/202315:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XFORX4 Pharmaceuticals Inc
21/03/202315:25Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XFORX4 Pharmaceuticals Inc
14/02/202316:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XFORX4 Pharmaceuticals Inc
12/12/202213:35TipRanksX4 Pharmaceuticals (XFOR) Receives a New Rating from Brookline Capital MarketsNASDAQ:XFORX4 Pharmaceuticals Inc
09/12/202205:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:XFORX4 Pharmaceuticals Inc
07/12/202206:12TipRanksX4 Pharma Tanks on Public OfferingNASDAQ:XFORX4 Pharmaceuticals Inc
30/11/202206:35TipRanksB.Riley Financial Keeps Their Buy Rating on X4 Pharmaceuticals (XFOR)NASDAQ:XFORX4 Pharmaceuticals Inc
29/11/202218:05TipRanksBrookline Capital Markets Sticks to Its Buy Rating for X4 Pharmaceuticals (XFOR)NASDAQ:XFORX4 Pharmaceuticals Inc
07/11/202220:07TipRanksX4 Pharmaceuticals (XFOR) Receives a Buy from Stifel NicolausNASDAQ:XFORX4 Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:XFOR

Su Consulta Reciente

USOTC
BASFY
BASF (QX)
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
TSLA
Tesla
AMEX
XLV
Health Care Select Sector
NYSE
BAC
Bank of America
NYSE
KO
Coca Cola
CCOM
OILBRENT
Brent Oil
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
AMZN
Amazon.com
USOTC
RHHBY
Roche (QX)
NYSE
VZ
Verizon Communications
SPI
SP500
S&P 500
CCOM
US500
US 500
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados